Search hospitals > Kentucky > Louisville
Jewish Hospital
Claim this profileLouisville, Kentucky 40202
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
226 reported clinical trials
4 medical researchers
Summary
Jewish Hospital is a medical facility located in Louisville, Kentucky. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Jewish Hospital is involved with conducting 226 clinical trials across 425 conditions. There are 4 research doctors associated with this hospital, such as Richard L. Deming, Mark Slaughter, MD, Mehmet S. Copur, and Narish Solankhi, M.D..Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Richard L. DemingMercy Medical Center - Des Moines4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
172 reported clinical trials
239 drugs studied
Mark Slaughter, MDJewish Hospital4 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Heart Failure
3 reported clinical trials
5 drugs studied
Mehmet S. CopurBethesda North Hospital12 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
2 reported clinical trials
8 drugs studied
Narish Solankhi, M.D.Jewish Hospital2 years of reported clinical research
Studies Aortic Valve Stenosis
1 reported clinical trial
2 drugs studied
Clinical Trials running at Jewish Hospital
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Cancer
Bladder Carcinoma
Squamous Cell Carcinoma
Anal Cancer
Tumors
Multiple Myeloma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Sacituzumab Govitecan
for Brain Metastases from Breast Cancer
This phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases). Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted therapy because it attaches to specific molecules on the surface of cancer cells, known as Trop-2 receptors, and delivers govitecan to kill them. Giving sacituzumab govitecan may shrink the cancer in the brain and/or extend the time until the cancer gets worse.
Recruiting1 award Phase 212 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Jewish Hospital?
Jewish Hospital is a medical facility located in Louisville, Kentucky. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Jewish Hospital is involved with conducting 226 clinical trials across 425 conditions. There are 4 research doctors associated with this hospital, such as Richard L. Deming, Mark Slaughter, MD, Mehmet S. Copur, and Narish Solankhi, M.D..